Rallybio Sets 1-for-2 Reverse Stock Split for November 20

• Rallybio plans a one-for-two reverse stock split effective at 12:01 a.m. Eastern Time on November 20, 2026, ahead of its Avenzo merger.
• The consolidation will reduce outstanding common shares from approximately 5,600,000 to 2,800,000 before the merger closes.
• Fractional shares will be paid in cash based on the stock’s closing price on the split’s effective date.
• Following Nasdaq approvals and merger completion, the combined company plans to trade as Avenzo Therapeutics under the symbol AVZO.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rallybio Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202611101715BIZWIRE_USPR_____20261108_BW364985) on November 10, 2026, and is solely responsible for the information contained therein.